KHALED SAID: Open Payments
NPI 1871099457 · SCRANTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$325 in 14 payments from 7 companies in 2025. Trend: 2023 $202 · 2024 $169 · 2025 $325
Food & beverage: $325
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $100 |
| E.R. Squibb & Sons, L.L.C. | 4 | $93 |
| Janssen Pharmaceuticals, Inc | 2 | $48 |
| Lundbeck LLC | 1 | $28 |
| Sage Therapeutics, LLC | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $14 |
Products named: INGREZZA, COBENFY, SPRAVATO, REXULTI, ZURZUVAE, AUSTEDO XR, VRAYLAR.
Industry payments across PA — which companies pay providers there.
